Warfarin initiation and the potential role of genomic-guided dosing.
Lee
Craig R
CR
D000925:Anticoagulants / Q000494:pharmacology*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D065729:Cytochrome P-450 CYP2C9; D016678:Genome; D006801:Humans; D019934:International Normalized Ratio; D010597:Pharmacogenetics / Q000379:methods*; D016896:Treatment Outcome; D014812:Vitamin K / Q000378:metabolism; D014859:Warfarin / Q000494:pharmacology*
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases